{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:13:22Z","timestamp":1790007202598,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Phys Med Rehabil"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of the study was to investigate the therapeutic effect of transcutaneous electrical nerve stimulation on neurogenic overactive bladder that is refractory to pharmacotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This randomized trial recruited 83 participants with neurogenic overactive bladder that were nonresponsive to 3-mo first-line anticholinergic drug treatment. Participants were randomized into treatment and control groups. Transcutaneous electrical nerve stimulation current consisting of biphasic square wave with pulse durations of 150 \u03bcs and pulse frequency set at 20 Hz were applied to for 30 mins once a day for 90 days. Stimulation was provided over the lateral aspect of the sacrum bilaterally of the electrodes. Patients in the transcutaneous electrical nerve stimulation group stopped taking the anticholinergic drugs. The control group continued to receive anticholinergic drugs for 90 days. The participants\u2019 Overactive Bladder Symptom Score, the Medical Outcomes Study 36-Item Short-Form Health Survey scores, urodynamic values, and voiding diary data were assessed before and after the therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The transcutaneous electrical nerve stimulation treatment group had significantly decreased Overactive Bladder Symptom scores compared with the control group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001); in addition, half of the Medical Outcomes Study 36-Item Short-Form Health Survey scores were significantly improved in the transcutaneous electrical nerve stimulation group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). The patients treated with transcutaneous electrical nerve stimulation improved significantly voiding diary parameters at <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05. Similarly, urodynamic values at <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 favored the experimental group over the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Applying daily transcutaneous electrical nerve stimulation over the sacral region for 90 days to patient with neurogenic overactive bladder improved overactive bladder symptoms of patients whose response to anticholinergic drugs is far inferior.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>To Claim CME Credits<\/jats:title>\n            <jats:p>Complete the self-assessment activity and evaluation online at http:\/\/www.physiatry.org\/JournalCME\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CME Objectives<\/jats:title>\n            <jats:p>Upon completion of this article, the reader should be able to: (1) Determine the therapeutic effect of transcutaneous electrical nerve stimulation (TENS) on neurogenic overactive bladder (NOAB); (2) Demonstrate the effectiveness of reflex suppression of the bladder using the TENS applied over the sacral region as a stimulation location; and (3) Confirm the TENS method using biphasic square waves with pulse durations of 150 \u03bcs and pulse frequencies of 20 Hz as applied is shown to be superior to anticholinergic drugs in managing NOAB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level<\/jats:title>\n            <jats:p>Advanced<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Accreditation<\/jats:title>\n            <jats:p>The Association of Academic Physiatrists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.<\/jats:p>\n            <jats:p>The Association of Academic Physiatrists designates this journal-based CME activity for a maximum of <jats:italic toggle=\"yes\">1.0 AMA PRA Category 1 Credit(s)<\/jats:italic>\u2122. Physicians should only claim credit commensurate with the extent of their participation in the activity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phm.0000000000001836","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:28:50Z","timestamp":1625531330000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder"],"prefix":"10.1097","volume":"101","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"bib1-20250616","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","article-title":"Tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction","volume":"108","year":"2011","journal-title":"BJU Int"},{"key":"bib2-20250616","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nau.21003","article-title":"Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database","volume":"30","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"bib3-20250616","first-page":"180","article-title":"Research progress of neurogenic bladder overactivity (review)","volume":"2","year":"2015","journal-title":"Chin Rehabil Theory Pract"},{"key":"bib4-20250616","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353274","article-title":"Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder","volume":"41","year":"2013","journal-title":"Neuroepidemiology"},{"key":"bib5-20250616","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/nau.21072","article-title":"Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China","volume":"30","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"bib6-20250616","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-5347(17)55850-4","article-title":"Electrical stimulation and interstitial cystitis","volume":"123","year":"1980","journal-title":"J Urol"},{"key":"bib7-20250616","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1464-4096.2001.02422.x","article-title":"Transcutaneous electrical nerve stimulation in the treatment of neurological patients with urinary symptoms","volume":"88","year":"2001","journal-title":"BJU Int"},{"key":"bib8-20250616","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00192-012-1691-5","article-title":"A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction","volume":"23","year":"2012","journal-title":"Int Urogynecol J"},{"key":"bib9-20250616","first-page":"851","article-title":"Transcutaneous electrical nerve stimulation in the treatment of patients with poststroke urinary incontinence","volume":"9","year":"2014","journal-title":"Clin Interv Aging"},{"key":"bib10-20250616","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PHM.0000000000000360","article-title":"Effects of transcutaneous electrical nerve stimulation at two frequencies on urinary incontinence in poststroke patients: a randomized controlled trial","volume":"95","year":"2016","journal-title":"Am J Phys Med Rehabil"},{"key":"bib11-20250616","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1442-2042.2008.02080.x","article-title":"Neuromodulation for the treatment of urinary incontinence","volume":"15","year":"2008","journal-title":"Int J Urol"},{"key":"bib12-20250616","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00345-012-0888-z","article-title":"Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?","volume":"31","year":"2013","journal-title":"World J Urol"},{"key":"bib13-20250616","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jpurol.2014.03.017","article-title":"Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: a randomized controlled trial","volume":"10","year":"2014","journal-title":"J Pediatr Urol"},{"key":"bib14-20250616","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0404.1993.tb05514.x","article-title":"Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population","volume":"87","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"bib15-20250616","first-page":"1","article-title":"To discuss the mechanism of the urinary incontinence due to the cerebrovascular accident","volume":"27","year":"2007","journal-title":"Int J Urol Nephrol"},{"key":"bib17-20250616","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","article-title":"Symptom assessment tool for overactive bladder syndrome\u2014Overactive Bladder Symptom Score","volume":"68","year":"2006","journal-title":"Urology"},{"key":"bib18-20250616","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/nau.22336","article-title":"Burden of overactive bladder symptom on quality of life in stroke patients","volume":"32","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"bib19-20250616","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","year":"1992","journal-title":"Med Care"},{"key":"bib20-20250616","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5213\/inj.1938086.043","article-title":"Urodynamic mechanisms underlying overactive bladder symptoms in patients with Parkinson disease","volume":"23","year":"2019","journal-title":"Int Neurourol J"},{"key":"bib21-20250616","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: report from the standardization subcommittee of the International Continence Society","volume":"21","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"bib22-20250616","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40273-018-0663-0","article-title":"Review of economic value drivers of the treatment of overactive bladder","volume":"36","year":"2018","journal-title":"Pharmacol Econ"},{"key":"bib23-20250616","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01907070","article-title":"TENS: a treatment option for bladder dysfunction","volume":"7","year":"1996","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"bib24-20250616","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/nau.22545","article-title":"Does patterned afferent stimulation of sacral dermatomes suppress urethral sphincter reflexes in individuals with spinal cord injury?","volume":"34","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"bib25-20250616","first-page":"17","article-title":"Efficacy of transcutaneous electrical nerve stimulation in the treatment of overactive bladder","volume":"10","year":"2016","journal-title":"J Clin Diagn Res"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000001836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:10:51Z","timestamp":1750108251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000001836"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000001836","relation":{},"ISSN":["1537-7385","0894-9115"],"issn-type":[{"value":"1537-7385","type":"electronic"},{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}